ArticlePharmacoEconomics2019

Cost-Effectiveness of Betrixaban Compared with Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients with Acute Medical Illness in the United States.

Holly Guy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.